In terms of breast cancer, both genetic suppression by RNA interference approach and pharmacological inhibition by small molecular antagonist of RRM2 gene significantly reversed tamoxifen-resistant cell proliferation, reduced cell motility, activated pro-apoptotic pathways, and decreased tumor growth [11–13]. Here, RRM2 is linked to breast cancer.